Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial cooperation platform that...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E.
Target Price
The average target price of 2576.HK is 6.7 and suggests 38% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell